Indivior Pharmaceuticals (INDV) Current Taxes (2021 - 2026)

Indivior Pharmaceuticals' Current Taxes history runs 6 years deep, the most recent figure standing at $26.0 million for Q1 2026.

• In Q1 2026, Current Taxes rose 116.67% year-over-year to $26.0 million; the TTM figure through Mar 2026 stood at $26.0 million (up 116.67% YoY), while the FY2025 annual figure was $2.0 million, down 71.43% from the prior year.
• Current Taxes was $26.0 million for Q1 2026 at Indivior Pharmaceuticals, up from $2.0 million in the prior quarter.
• In the past five years, Current Taxes ranged from a high of $26.0 million in Q1 2026 to a low of $2.0 million in Q4 2025.
• Historically, Current Taxes has averaged $10.6 million across 5 years, with a median of $8.5 million in 2022.
• The sharpest annual moves came in 2025 and 2026: Current Taxes plunged 71.43% in 2025, then jumped 116.67% in 2026.
• A 5-year view of Current Taxes shows it stood at $9.0 million in 2022, then decreased by 11.11% to $8.0 million in 2023, then decreased by 12.5% to $7.0 million in 2024, then slumped by 71.43% to $2.0 million in 2025, then jumped by 1200.0% to $26.0 million in 2026.
• The last three Current Taxes figures came in at $26.0 million (Q1 2026), $2.0 million (Q4 2025), and $4.0 million (Q3 2025), per Business Quant data.